VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
VNRX on NYSE
Shares outstanding
107,573,681
Price per share
$0.26
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
26,125,378
Total reported value
$17,729,734
% of total 13F portfolios
0%
Share change
+2,140,218
Value change
+$1,443,847
Number of holders
32
Price from insider filings
$0.26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lagoda Investment Management, L.P. 11% +6.7% $8,193,500 +$1,057,700 11,705,000 +15% Lagoda Investment Management, L.P. 30 Jun 2025
ARMISTICE CAPITAL, LLC 8.7% -13% $5,173,304 -$233,796 9,380,425 -4.3% Armistice Capital, LLC 30 Sep 2025

As of 30 Sep 2025, 32 institutional investors reported holding 26,125,378 shares of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX). This represents 24% of the company’s total 107,573,681 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) together control 24% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Lagoda Investment Management, L.P. 12% 12,487,000 +6.7% 4.8% $8,476,176
ARMISTICE CAPITAL, LLC 8.7% 9,380,425 +10% 0.2% $6,367,432
VANGUARD GROUP INC 1.4% 1,530,048 -5.8% 0% $1,038,903
GEODE CAPITAL MANAGEMENT, LLC 0.82% 878,170 +15% 0% $596,218
BlackRock, Inc. 0.41% 445,187 0% 0% $302,193
CITADEL ADVISORS LLC 0.31% 329,520 +70% 0% $223,678
STATE STREET CORP 0.25% 268,638 +82% 0% $182,351
Silverberg Bernstein Capital Management LLC 0.22% 232,082 +16% 0.1% $157,426
NORTHERN TRUST CORP 0.18% 192,860 +64% 0% $130,913
RENAISSANCE TECHNOLOGIES LLC 0.07% 78,000 +280% 0% $52,946
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.06% 68,570 0% 0% $46,545
Virtu Financial LLC 0.04% 40,733 0% $28,000
XTX Topco Ltd 0.03% 35,682 0% $24,221
Bank of New York Mellon Corp 0.03% 30,596 0% 0% $20,769
MILLENNIUM MANAGEMENT LLC 0.03% 29,369 0% $19,936
Cetera Investment Advisers 0.02% 20,050 0% $13,610
HRT FINANCIAL LP 0.02% 16,569 +38% 0% $11,000
Chicago Partners Investment Group LLC 0.02% 16,168 -8.7% 0% $6,867
UBS Group AG 0.01% 14,827 +977% 0% $10,068
Creative Planning 0.01% 10,056 0% 0% $6,826
ROYAL BANK OF CANADA 0.01% 6,600 +120% 0% $4,000
Tower Research Capital LLC (TRC) 0% 4,408 -17% 0% $2,992
Ameritas Advisory Services, LLC 0% 4,000 0% 0% $2,715
Founders Capital Management 0% 2,000 0% 0% $1,358
BANK OF AMERICA CORP /DE/ 0% 960 +5.5% 0% $650

Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 249,282 $63,716 +$3,038 $0.26 1
2025 Q3 26,125,378 $17,729,734 +$1,443,847 $0.68 32
2025 Q2 23,985,160 $18,228,005 +$2,275,048 $0.76 28
2025 Q1 21,008,583 $11,976,111 +$1,320,422 $0.57 24
2024 Q4 18,689,942 $11,213,733 +$697,546 $0.60 26
2024 Q3 17,526,713 $10,533,642 +$5,772,495 $0.60 23
2024 Q2 7,992,589 $4,835,640 +$105,463 $0.60 27
2024 Q1 7,785,670 $5,893,961 +$1,078,611 $0.76 23
2023 Q4 6,366,411 $4,564,679 -$9,638 $0.72 27
2023 Q3 6,308,141 $4,346,471 -$839 $0.69 28
2023 Q2 6,463,590 $8,987,624 +$71,429 $1.39 33
2023 Q1 6,416,306 $12,217,662 +$347,989 $1.91 38
2022 Q4 6,188,644 $15,038,871 +$971,599 $2.43 31
2022 Q3 5,359,889 $7,289,360 -$137,360 $1.36 27
2022 Q2 5,950,529 $12,199,718 -$274,144 $2.05 28
2022 Q1 6,063,122 $18,251,044 +$356,303 $3.01 30
2021 Q4 5,943,047 $18,664,090 -$667,185 $3.14 33
2021 Q3 6,179,622 $19,156,762 -$814,637 $3.10 34
2021 Q2 6,518,468 $21,448,255 -$7,664,649 $3.29 44
2021 Q1 8,718,638 $32,952,841 +$4,431,713 $3.78 52
2020 Q4 7,545,557 $29,347,913 +$2,766,567 $3.89 45
2020 Q3 6,842,462 $21,961,861 +$1,352,055 $3.21 45
2020 Q2 6,380,058 $24,816,004 +$11,989,596 $3.89 53
2020 Q1 3,340,510 $10,389,448 +$296,694 $3.11 28
2019 Q4 3,170,783 $15,026,166 +$110,802 $4.74 35
2019 Q3 3,109,395 $17,472,952 +$600,266 $5.62 31
2019 Q2 2,996,559 $9,410,646 -$91,671 $3.14 24
2019 Q1 3,024,008 $9,827,369 +$985,476 $3.25 25
2018 Q4 2,755,859 $4,986,901 -$1,176,375 $1.81 25
2018 Q3 3,191,934 $8,349,029 -$3,189,788 $2.59 24
2018 Q2 4,441,353 $8,888,150 -$485,340 $2.00 24
2018 Q1 4,665,394 $11,196,780 +$281,544 $2.40 24
2017 Q4 4,547,367 $13,369,331 -$275,296 $2.94 18
2017 Q3 4,670,127 $12,311,292 -$633,762 $2.63 19
2017 Q2 4,904,719 $17,350,000 +$817,929 $3.54 17
2017 Q1 4,673,715 $18,787,000 -$465,457 $4.01 17
2016 Q4 4,798,201 $21,910,000 +$1,445,217 $4.57 16
2016 Q3 4,478,056 $23,862,000 +$7,568,559 $5.30 16
2016 Q2 3,067,113 $9,659,000 +$59,820 $3.14 14
2016 Q1 3,046,217 $10,814,000 +$7,611,332 $3.55 14
2015 Q4 899,396 $4,048,000 -$220,211 $4.51 12
2015 Q3 948,073 $4,246,000 +$430,028 $4.46 8
2015 Q2 854,891 $3,376,000 -$143,145 $3.93 6
2015 Q1 889,690 $3,656,000 +$3,655,999 $4.10 8